GSTM1 and Schnyder corneal dystrophy: These findings suggest that these ratios have potential diagnostic and prognostic applications that can be applied in clinical settings to differentiate between sickle Hb subgroups, assess disease complications, and guide personalized management strategies for sickle cell disease (SCD) patients.